RonaCare® VTA - Extra Cellular Matrix Protector
EMD`s RonaCare® VTA is a new age-defying concept. It comprises a liposome containing Rutinyl Sulfate, Magnesium Ascorbyl Phosphate (MAP) and L-Hydroxyproline (LHP). Encapsulated in and delivered through the RonaCare® VTA liposome, the active ingredients show complementary anti-enzymatic, anti-oxidant and protecting properties resulting in substantial protection of hyaluronic acid and other essential compounds of the Extra Cellular Matrix.
Features and benefits
RonaCare® VTA has a highly protective effect on hyaluronic acid and sulfated glycosaminoglycans. In the case of the hyaluronic acid, RonaCare® VTA secures skin moisture, maintain turgescence and tonus of the skin and prevents collagen cross-links. In the case of sulfated glycosaminoglycanes, RonaCare® VTA supports regulation and improves the transport mechanism of growth factors in the dermis. Furthermore it improves the skin physiology.
| In Vivo Efficacy | |
|---|---|
| Before treatment: | After treatment with 4 % RonaCare® VTA for four weeks: |
|
|
|
After 4 weeks treatment with RonaCare® VTA, an improvement in skin smoothness and reduction of wrinkle depth by more than 20 percent was observed.
| Further Efficacy Studies |
|---|
|
You will find all relevant documents and certificates concerning your chosen product under the heading 'Related Documents'. Brochures are available on request.
